Table 1 Clinicopathologic and demographic characteristics of breast cancer patients and control groups
Breast cancer patients (n = 75) | Control (n = 37) | P value | ||
|---|---|---|---|---|
Age (years): median (IQR) | 53 (41–64) | 53 (38–63) | 0.862 | |
Menopausal status | ||||
Premenopausal | 32 (42.7%) | 20 (54.1%) | 0.256 | |
Postmenopausal | 43 (57.3%) | 17 (45.9%) | ||
Tumor stage | ||||
Stage I | 3 (4%) | |||
Stage II | 25 (33.3%) | |||
Stage III | 28 (37.3%) | |||
Stage IV | 19 (25.3%) | |||
Node metastasis | ||||
Yes | 52 (69.3%) | |||
No | 23 (30.7%) | |||
Distant Metastasis | ||||
Yes | 19 (25.3%) | |||
No | 56 (74.7%) | |||
ER status | ||||
Positive | 56 (74.7%) | |||
Negative | 18 (24%) | |||
Unknown | 1 (1.3%) | |||
PR status | ||||
Positive | 53 (70.7%) | |||
Negative | 21 (28%) | |||
Unknown | 1 (1.3%) | |||
HER2 status | ||||
Positive | 29 (38.7%) | |||
Negative | 37 (49.3%) | |||
Unknown | 9 (12%) | |||
Ki-67 | ||||
High | 60 (80%) | |||
Low | 10 (13.3%) | |||
Unknown | 5 (6.7%) | |||